BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11523187)

  • 1. Hard choices when breast cancer threatens.
    Mayes JR
    JAAPA; 2001 Mar; 14(3):6, 9. PubMed ID: 11523187
    [No Abstract]   [Full Text] [Related]  

  • 2. What genetic testing can tell you about breast cancer risk.
    Welch MA
    JAAPA; 2001 Mar; 14(3):50-2, 57-8, 61. PubMed ID: 11523186
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening and management of hereditary breast cancer.
    Legare RD
    Med Health R I; 1999 May; 82(5):172-5. PubMed ID: 10343496
    [No Abstract]   [Full Text] [Related]  

  • 4. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
    Lester J
    Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 7. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
    Loman N
    Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for patients at risk for inheritable breast cancer: how the nurse practitioner can determine the proper course of action to ensure desired outcomes.
    Fowler MC
    Nurse Pract Forum; 1999 Dec; 10(4):204-7. PubMed ID: 10776261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a randomized study of telephone versus in-person breast cancer risk counseling.
    Helmes AW; Culver JO; Bowen DJ
    Patient Educ Couns; 2006 Dec; 64(1-3):96-103. PubMed ID: 16427245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. For the benefit of all.
    Durfy SJ; Peters JA
    Hastings Cent Rep; 1993; 23(5):28-9; discussion 29-30. PubMed ID: 8262767
    [No Abstract]   [Full Text] [Related]  

  • 12. Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Schwartz MD; Tercyak KP; Peshkin BN; Valdimarsdottir H
    Nat Clin Pract Oncol; 2005 Jan; 2(1):24-5. PubMed ID: 16264852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Predictive oncology and familial breast cancer].
    Pescia G; Perey L
    Rev Med Suisse Romande; 1997 Aug; 117(8):603-6. PubMed ID: 9340715
    [No Abstract]   [Full Text] [Related]  

  • 14. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
    Riem L
    MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer genetic risk assessment for individuals at risk of familial breast cancer.
    Guirguis-Blake J
    Am Fam Physician; 2008 Feb; 77(4):449-50. PubMed ID: 18326163
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling familial clustered breast cancer using published data.
    Jonker MA; Jacobi CE; Hoogendoorn WE; Nagelkerke NJ; de Bock GH; van Houwelingen JC
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1479-85. PubMed ID: 14693741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
    Shah MR
    Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a risk assessment tool for women with a family history of breast cancer.
    Braithwaite D; Sutton S; Mackay J; Stein J; Emery J
    Cancer Detect Prev; 2005; 29(5):433-9. PubMed ID: 16055276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.